Michael Gray
Overview
Michael Gray received an average of $879K in total compensation, including $424K in salary, at IMARA between 2020 and 2021. Michael Gray also received an average of $1M at X4 Pharmaceuticals from 2016 to 2019 and an average of $542K at Mellanox Technologies from 2006 to 2012.
- 2021
- 2020
- 2019
- 2018
- 2017
- 2016
- 2012
- 2011
- 2010
- 2009
IMARAChief Financial Officer and Chief Operating Officer
IMARAChief Financial Officer and Chief Operating Officer
X4 PharmaceuticalsFormer President, Chief Executive Officer and Chief Financial Officer
X4 PharmaceuticalsFormer President, Chief Executive Officer and Chief Financial Officer
X4 PharmaceuticalsChief Operating Officer and Chief Financial Officer
X4 PharmaceuticalsChief Operating Officer and Chief Financial Officer
Mellanox TechnologiesFormer Chief Financial Officer
Mellanox TechnologiesFormer Chief Financial Officer
Mellanox TechnologiesFormer Chief Financial Officer
Mellanox TechnologiesChief Financial Officer
Source: SEC filings on April 22, 2022, April 28, 2020, May 22, 2019, April 23, 2018, April 9, 2013, April 18, 2012, April 8, 2011, April 12, 2010, and April 9, 2009.
Related executives
We found 22 more executives who work or worked at IMARA, X4 Pharmaceuticals, andMellanox Technologies.
Paula Ragan
X4 Pharmaceuticals
Chief Executive Officer
Adam Mostafa
X4 Pharmaceuticals
Chief Financial Officer
Mary DiBiase
X4 Pharmaceuticals
Chief Operating Officer
Rahul Ballal
IMARA
Chief Executive Officer
Kenneth Attie
IMARA
Chief Medical Officer
Derek Meisner
X4 Pharmaceuticals
Chief Legal Officer
Michael Gray
IMARA
Chief Financial Officer
Willem Scheele
IMARA